Developmental changes in the expression of alpha-, beta- and gamma-subspecies of protein kinase C at synapses in the ventral horn of the embryonic and postnatal rat spinal cord

A comparative analysis of rod bipolar cell transcriptomes identifies novel genes implicated in night vision

In the mammalian retina, rods and a specialised rod-driven signalling pathway mediate visual responses under scotopic (dim light) conditions. As rods primarily signal to rod bipolar cells (RBCs) under scoptic conditions, disorders that affect rod or RBC function are often associated with impaired night vision. To identify novel genes expressed by RBCs and, therefore, likely to be involved in night vision, we took advantage of the adult Bhlhe23^−/− mouse retina (that lacks RBCs) to derive the RBC transcriptome. We found that genes expressed by adult RBCs are mainly involved in synaptic structure and signalling, whereas genes that influence RBC development are also involved in the cell cycle and transcription/translation. By comparing our data with other published retinal and bipolar cell transcriptomes (where we identify RBCs by the presence of Prkca and/or Pcp2 transcripts), we have derived a consensus for the adult RBC transcriptome. These findings ought to facilitate further research into physiological mechanisms underlying mammalian night vision as well as proposing candidate genes for patients with inherited causes of night blindness.

How important is protein kinase C in μ-opioid receptor desensitization and morphine tolerance?

The repeated administration of opiate drugs such as morphine results in the development of tolerance to their analgesic, rewarding (euphoric) and respiratory-depressant effects; thus, to obtain the same level of response with subsequent administrations, a greater dose must be used. Tolerance can limit the clinical efficacy of opiate drugs and enhance the social problems that are inherent in recreational opioid abuse. Surprisingly, the mechanism (or mechanisms) underlying the development of morphine tolerance remains controversial. Here, we propose that protein kinase C could have a crucial role in the desensitization of mu-opioid receptors by morphine and that this cellular process could contribute to the development and maintenance of morphine tolerance in vivo.

Determination of the role of conventional, novel and atypical PKC isoforms in the expression of morphine tolerance in mice

This study comprehensively determines the role of all the major PKC isoforms in the expression morphine tolerance. Pseudosubstrate and receptors for activated C-kinase (RACK) peptides inhibit only a single PKC isoform, while previously tested chemical PKC inhibitors simultaneously inhibit multiple isoforms making it impossible to determine which PKC isoform mediates morphine tolerance. Tolerance can result in a diminished effect during continued exposure to the same amount of substance. In rodents, morphine pellets provide sustained exposures to morphine leading to the development of tolerance by 72 h. We hypothesized that administration of the PKC isoform inhibitors i.c.v. would reverse tolerance and reinstate antinociception in the tail immersion and hot plate tests from the morphine released solely from the pellet. Inhibitors to PKC alpha, gamma and epsilon (100-625 pmol) dose-dependently reinstated antinociception in both tests. The PKC beta(I), beta(II), delta, theta, epsilon, eta and xi inhibitors were inactive (up to 2500 pmol). In other mice, the degree of morphine tolerance was determined by calculating ED50 and potency-ratio values following s.c. morphine administration. Morphine s.c. was 5.6-fold less potent in morphine-pelleted vs. placebo-pelleted mice. Co-administration of s.c. morphine with the inhibitors i.c.v. to either PKC alpha (625 pmol), gamma (100 pmol) or epsilon (400 pmol) completely reversed the tolerance so that s.c. morphine was equally potent in both placebo- and morphine-pelleted mice. The PKC beta(I), beta(II), delta, theta, epsilon, eta and xi inhibitors were inactive. Thus, PKC alpha, gamma and epsilon appear to contribute to the expression of morphine tolerance in mice.

Early signs of motoneuron vulnerability in a disease model system: Characterization of transverse slice cultures of spinal cord isolated from embryonic ALS mice

Mutations in the SOD1 gene are associated with familial amyotrophic lateral sclerosis. The mechanisms by which these mutations lead to cell loss within the spinal cord ventral horns are unknown. In the present report we used the G93A transgenic mouse model of amyotrophic lateral sclerosis to develop and characterize an in vitro tool for the investigation of subtle alterations of spinal tissue prior to frank neuronal degeneration. To this aim, we developed organotypic slice cultures from wild type and G93A embryonic spinal cords. We combined immunocytochemistry and electron microscopy techniques to compare wild type and G93A spinal cord tissues after 14 days of growth under standard in vitro conditions. By SMI32 and choline acetyl transferase immunostaining, the distribution and morphology of motoneurons were compared in the two culture groups. Wild type and mutant cultures displayed no differences in the analyzed parameters as well as in the number of motoneurons. Similar results were observed when glial fibrillary acidic protein and myelin basic protein-positive cells were examined. Cell types within the G93A slice underwent maturation and slices could be maintained in culture for at least 3 weeks when prepared from embryos. Electron microscopy investigation confirmed the absence of early signs of mitochondria vacuolization or protein aggregate formation in G93A ventral horns. However, a significantly different ratio between inhibitory and excitatory synapses was present in G93A cultures, when compared with wild type ones, suggesting the expression of subtle synaptic dysfunction in G93A cultured tissue. When compared with controls, G93A motoneurons exhibited increased vulnerability to AMPA glutamate receptor-mediated excitotoxic stress prior to clear disease appearance. This in vitro disease model may thus represent a valuable tool to test early mechanisms contributing to motoneuron degeneration and potential therapeutic molecular interventions.

Protein kinase Cgamma mediates ethanol withdrawal hyper-responsiveness of NMDA receptor currents in spinal cord motor neurons

The present studies were designed to test the hypothesis that neuronal-specific protein kinase Cgamma (PKCgamma) plays a critical role in acute ethanol withdrawal hyper-responsiveness in spinal cord. Patch-clamp studies were carried out in motor neurons in neonatal rat spinal cord slices. Postsynaptic currents were evoked by brief pulses of 2 mM N-methyl-D-aspartic acid (NMDA) in the presence of bicuculline methiodide 10 microM; strychnine 5 microM and tetrodotoxin 0.5 microM. Both ethanol depression and withdrawal hyper-responsiveness of NMDA-evoked currents are dependent on increases in intracellular Ca(2+). Blocking intracellular increase in Ca(2+) by 30 mM 1,2-bis(2-aminophenoxy)-ethane-N,N,N',N'-tetraacetic acid (BAPTA) not only decreased the ethanol-induced depression of NMDA-evoked currents (33+/-5% in control vs 20+/-3% in BAPTA, P<0.05) but also eliminated acute ethanol withdrawal hyper-responsiveness. Immunohistochemistry studies revealed that neonatal spinal cord motor neurons contain an abundance of nuclear PKCgamma. Exposure to ethanol (100 mM) induced PKCgamma translocation from the nucleus to cytoplasm in motor neurons. Pretreatment with the gamma-isozyme-specific peptide PKC inhibitor, gammaV5-3, blocked ethanol-induced translocation and also blocked withdrawal hyper-responsiveness. The results show that PKCgamma mediates ethanol withdrawal hyper-responsiveness in spinal motor neurons; the results may be relevant to some symptoms of ethanol withdrawal in vivo.

Spatiotemporal distribution of neuronal calcium sensor-1 in the developing rat spinal cord

The present study revealed the localization of neuronal calcium sensor (NCS)-1 immunoreactivity (IR) in the developing rat spinal cord. The NCS-1 IR first appeared at embryonic day 12 in the peripheral nerves and their somata. Intense NCS-1 IR was expressed in ascending and descending tracts in the white matter during the late prenatal period, which gradually decreased to the faint level during postnatal development. Intense NCS-1 IR was colocalized with growth associated protein (GAP)-43 IR in the marginal zone and with the glutamate-aspartate transporter (GLAST) IR in the radial processes traversing the marginal zone. In the adult rat white matter, radially oriented astrocytes and astrocytes in the glia limitans were double-labeled for NCS-1 and glial fibrillary acidic protein (GFAP), whereas small dots on finger-like dendritic projections were double-labeled for NCS-1 and synaptophysin. In the developing gray matter, the NCS-1 IR appeared at embryonic day 12 and gradually increased in the neuronal somata and neuropil, reaching a plateau after the end of the 4th postnatal week. The small dots in neuropil were colabeled for NCS-1 and GFAP or NCS-1 and synaptophysin in the adult rat gray matter. These results strongly suggest that NCS-1 is involved in axogenesis and synaptogenesis in the developing rat spinal cord. NCS-1 can serve as a Ca(2+)-sensor not only in neurons but also in radial glial cells or even in radially oriented astrocytes in the adult rat spinal cord.

Effect of protein kinase C activation on the glycine evoked Cl− current in spinal cord neurons

We investigated whether the effect of phorbol-12-myristate-13-acetate (PMA) was altered by a kinase inhibitor and by down-regulation of protein kinase C (PKC) in order to determine if glycine receptors in mouse spinal neurons, unlike those in hippocampal and trigeminal neurons, can be inhibited by PKC. To examine the above, electrophysiological and immunofluorescence studies were carried out in mouse spinal neurons kept in culture for up to 3 weeks. The inhibition of the glycine activated current by PMA (1 microM) increased from 12+/-3% during week 1 to 27+/-6% during week 3. The effect of PMA was completely blocked by the PKC selective inhibitor RO 31-8220 (1 microM). After culturing the cells with 1 microM PMA for 24 h, the inhibitory effect of acute application of PMA disappeared altogether, suggesting that the effect of PMA was via PKC. Immunofluorescence studies showed that a short stimulation with PMA translocated the enzyme to the periphery whereas longer term stimulation (24 h) down regulated the PKC signal. These results indicate that activation of PKC by PMA inhibits the glycine receptor in cultured spinal neurons and that its sensitivity changes during neuronal development.

Spatiotemporal distribution of GAP-43 in the developing rat spinal cord: a histological and quantitative immunofluorescence study

In the rat spinal cord we studied developmental changes in spatiotemporal expression of the growth-associated protein GAP-43, which is known to play an important role in neural development, axonal regeneration, and modulation of synaptic function. GAP-43 was expressed predominantly in the white matter at embryonic day 13 to postnatal day 7, evenly in the white and gray matter at the 2nd to the 3rd postnatal week, and predominantly in the gray matter after the 5th postnatal week. The shifting of predominance was quantitatively assessed. On the basis of histological findings and quantitative assessment of GAP-43 immunoreactivity, it appears likely that the development proceeds from the phase of mostly axonal elongation during the embryonic period and the 1st postnatal week, via the phase of axonal elongation and formation of end arbors and synaptic organization during the 2nd to the 4th postnatal week, to the phase of final maturation of synaptic organization. GAP-43 was continuously expressed through adulthood in neuropil of the gray matter, the pyramidal tract, and the dorsal portion of the lateral funiculus that was identified as serotonergic by confocal laser scanning microscopic studies. The continuous expression may imply perpetual remodeling in these structures even in adulthood.

Effects of lead on long-term potentiation in hippocampal CA3 vary with age

The effects of lead on long-term potentiation (LTP) in the hippocampal area CA3 were different in 30-day (P30) and 60-day-old (P60) rats upon either acute perfusion of lead to the isolated brain slice from controls or when recorded from slices from rats after chronic developmental exposure to lead. Lead caused a significant inhibition of LTP in 30-day CA3, and a significant potentiation in 60-day CA3 with either exposure paradigm. Consistent with the effects on LTP, lead inhibits phorbol ester-induced synaptic potentiation in 30-day rats and enhances phorbol ester-induced potentiation in 60-day rats. Protein kinase C (PKC) has been implicated in actions of lead but previous investigations have reported either a stimulation or a blockade of PKC by lead. Our results are consistent with the hypothesis that the effects of lead on LTP are mediated via an action on PKC, which varies with age.

Developmental expression of alpha-, beta- and gamma-subspecies of protein kinase C in the dorsal corticospinal tract in the rat spinal cord

Developmental expression of alpha-, beta- and gamma-subspecies of protein kinase C in the dorsal corticospinal tract was immunohistochemically investigated at the cervical level of the postnatal rat spinal cord. On postnatal day 0, immunoreactivity for these subspecies was uniformly distributed throughout the posterior funiculus. On postnatal day 7, immunoreactivity for this enzyme in the posterior funiculus began to decline. On postnatal days 14 and 21, the immunoreactivity in the posterior funiculus became weak, while the dorsal corticospinal tract forming in the most ventral portion of the posterior funiculus exhibited strong immunoreactivity for these three subspecies of protein kinase C. Thereafter, immunoreactivity in the corticospinal tract rapidly declined, and on postnatal days 28 and 35, weak immunoreaction was demonstrated as very fine granular deposits in the tract. Expression of this enzyme in the dorsal corticospinal tract at these stages resembled that in the adult rat. Electron microscopically, growth cones and nascent axonal shafts were first noted on postnatal day 2 in the most ventral portion of the posterior funiculus, and thereafter, the axonal shaft gradually thickened and on postnatal day 14 some axons began to be myelinated. The growth cones and thin axonal shafts randomly exhibited weak immunoreactivity in the axoplasm. The thicker unmyelinated axonal shafts showed distinct immunoreactivity uniformly throughout the axoplasm and along the axolemma as granular deposits. In these developing axons, intensity and distribution of immunoreactivity for all three subspecies were principally similar. In the mature myelinated axons, the intensity and distribution of immunoreactivity for each subspecies of protein kinase C were quite different, i.e. immunoreactivity for alpha-subspecies was randomly distributed on some cytoskeletal elements, and that for beta-subspecies was uniformly detected on most of the cytoskeletal elements. In contrast, immunoreactivity for gamma-subspecies was distributed mainly on the endoplasmic reticulum. These findings suggest that in growing corticospinal axons protein kinase C might be involved in several important aspects of axonal development, and that in mature axons this enzyme might participate in different aspects of axonal function.

Expression of alpha-, beta-, and gamma-subspecies of protein kinase C in the motor neurons in the embryonic and postnatal rat spinal cord

Using polyclonal antibodies against alpha-, beta- and gamma-subspecies of protein kinase C, developmental changes in expression of these subspecies in the motor neurons in the rat cervical spinal cord were immunohistochemically investigated. On embryonic day-12, the motor neurons began to differentiate from undifferentiated neuroepithelial cells. On embryonic day-13, they began to express weak immunoreactivity for alpha- and beta-protein kinase C and slightly more evident immunoreactivity for gamma-protein kinase C. Immunoreactivity for protein kinase C in these neurons gradually became stronger, as the development progressed. Between embryonic day-18 and postnatal day-7, the motor neurons showed distinct immunoreactivity in the nucleus, perikaryal cytoplasm, axon and dendrites. At these stages, distribution and intensity of immunoreactivity for alpha-, beta- and gamma-protein kinase C were very similar. Thereafter, the expression of this enzyme in the nucleus gradually declined, while in the other structures, expression of each subspecies changed independently. On postnatal day-28 and 35, expression of beta-protein kinase C in the axons was stronger than that of alpha- and gamma-protein kinase C, and immunoreactivity for gamma-protein kinase C in the perikaryal cytoplasm and dendrites was slightly weaker than that for alpha- and beta-protein kinase C. Expression of this enzyme in the motor neurons at these stages was almost the same as in the adult animal. Electron microscopically, immunoreactivity for protein kinase C was randomly distributed in the nucleus, and in the perikaryal cytoplasm, often near the cisterns of the endoplasmic reticulum. Expression of protein kinase C in the growing axons was quite different from that in the mature axons. In the dendrites, immunoreactivity for protein kinase C was distributed randomly in the cytoplasm and at the postsynaptic densities. These findings suggest that protein kinase C might regulate not only the neural functions, but also several aspects of the differentiation process in the motor neurons.